2.10
price down icon2.78%   -0.06
after-market アフターアワーズ: 2.09 -0.01 -0.48%
loading
前日終値:
$2.16
開ける:
$2.15
24時間の取引高:
65,191
Relative Volume:
0.97
時価総額:
$77.35M
収益:
$134.00K
当期純損益:
$-9.93M
株価収益率:
-5.6757
EPS:
-0.37
ネットキャッシュフロー:
$-6.72M
1週間 パフォーマンス:
-2.78%
1か月 パフォーマンス:
+35.48%
6か月 パフォーマンス:
+1.94%
1年 パフォーマンス:
+195.77%
1日の値動き範囲:
Value
$2.08
$2.21
1週間の範囲:
Value
$2.08
$2.28
52週間の値動き範囲:
Value
$0.52
$3.35

Entera Bio Ltd Stock (ENTX) Company Profile

Name
名前
Entera Bio Ltd
Name
セクター
Healthcare (1176)
Name
電話
972-2-532-7151
Name
住所
KIRYAT HADASSAH, MINRAV BUILDING, JERUSALEM
Name
職員
20
Name
Twitter
Name
次回の収益日
2024-11-12
Name
最新のSEC提出書
Name
ENTX's Discussions on Twitter

ENTX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
ENTX
Entera Bio Ltd
2.10 77.35M 134.00K -9.93M -6.72M -0.34
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
397.27 102.31B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
701.85 77.13B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
623.82 37.30B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
245.44 31.66B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
113.08 27.11B 3.30B -501.07M 1.03B -2.1146

Entera Bio Ltd Stock (ENTX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2021-03-22 開始されました Aegis Capital Buy

Entera Bio Ltd (ENTX) 最新ニュース

pulisher
Dec 07, 2024

We're Keeping An Eye On Entera Bio's (NASDAQ:ENTX) Cash Burn Rate - Simply Wall St

Dec 07, 2024
pulisher
Dec 01, 2024

Short Interest in Entera Bio Ltd. (NASDAQ:ENTX) Rises By 19.0% - MarketBeat

Dec 01, 2024
pulisher
Nov 20, 2024

Knoll Capital Management, LLC's Strategic Acquisition in Entera Bio Ltd - GuruFocus.com

Nov 20, 2024
pulisher
Nov 17, 2024

Entera Bio Ltd. (NASDAQ:ENTX) Short Interest Update - MarketBeat

Nov 17, 2024
pulisher
Nov 14, 2024

FY2024 EPS Estimate for Entera Bio Decreased by Analyst - MarketBeat

Nov 14, 2024
pulisher
Nov 11, 2024

HC Wainwright Reaffirms Buy Rating for Entera Bio (NASDAQ:ENTX) - MarketBeat

Nov 11, 2024
pulisher
Nov 08, 2024

Entera Bio Ltd. (ENTX) Quarterly 10-Q Report - Quartzy

Nov 08, 2024
pulisher
Nov 08, 2024

Entera Bio Ltd. (ENTX) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance

Nov 08, 2024
pulisher
Nov 08, 2024

Entera Bio Highlights Q3 2024 Financials and FDA Anticipation - TipRanks

Nov 08, 2024
pulisher
Nov 08, 2024

Entera Bio Reports Q3 2024 Financial Results and Provides Business Updates - The Manila Times

Nov 08, 2024
pulisher
Oct 29, 2024

Short Interest in Entera Bio Ltd. (NASDAQ:ENTX) Drops By 14.4% - MarketBeat

Oct 29, 2024
pulisher
Oct 13, 2024

Entera Bio Ltd. (NASDAQ:ENTX) Short Interest Up 38.4% in September - MarketBeat

Oct 13, 2024
pulisher
Oct 07, 2024

Entera Bio outlook steady as H.C. Wainwright backs potential of total hip BMD in osteoporosis care - Investing.com Australia

Oct 07, 2024
pulisher
Oct 07, 2024

Entera Bio (NASDAQ:ENTX) Rating Reiterated by HC Wainwright - MarketBeat

Oct 07, 2024
pulisher
Oct 04, 2024

Are Medical Stocks Lagging Argenx (ARGX) This Year? - Yahoo Finance

Oct 04, 2024
pulisher
Sep 30, 2024

ENTX & OPK Stock May Gain Following Positive PK/PD Research Data - MSN

Sep 30, 2024
pulisher
Sep 29, 2024

Entera Bio shares hold Buy rating on OXM study success By Investing.com - Investing.com Australia

Sep 29, 2024
pulisher
Sep 28, 2024

Entera Bio shares hold Buy rating on OXM study success - Investing.com

Sep 28, 2024
pulisher
Sep 27, 2024

Entera Bio's (ENTX) "Buy" Rating Reiterated at HC Wainwright - MarketBeat

Sep 27, 2024
pulisher
Sep 26, 2024

Entera Bio and OPKO Health report promising obesity treatment study By Investing.com - Investing.com Australia

Sep 26, 2024
pulisher
Sep 25, 2024

Entera Bio and OPKO Health report promising obesity treatment study - Investing.com

Sep 25, 2024
pulisher
Sep 25, 2024

Entera Bio And Opko Health Provide Update On Pk/Pd Results Of Oral Oxyntomodulin (Glp-1/Glucagon) Peptide Tablet Candidate For Obesity And Metabolic Disorders - XM

Sep 25, 2024
pulisher
Sep 25, 2024

Entera Bio and OPKO Health Provide Update on PK/PD Results of Oral Oxyntomodulin (GLP-1/Glucagon) Peptide - EIN News

Sep 25, 2024
pulisher
Sep 20, 2024

Is Entera Bio (ENTX) Stock Outpacing Its Medical Peers This Year? - MSN

Sep 20, 2024
pulisher
Sep 03, 2024

Is Entera Bio (ENTX) Outperforming Other Medical Stocks This Year? - MSN

Sep 03, 2024
pulisher
Sep 01, 2024

Entera Bio Ltd. (NASDAQ:ENTX) Sees Significant Increase in Short Interest - MarketBeat

Sep 01, 2024
pulisher
Aug 20, 2024

Entera Bio to Participate in Upcoming Investor and Scientific Conferences - GlobeNewswire

Aug 20, 2024
pulisher
Aug 15, 2024

All You Need to Know About Entera Bio (ENTX) Rating Upgrade to Buy - Yahoo Finance

Aug 15, 2024
pulisher
Aug 15, 2024

Entera Bio Ltd. Forecasted to Earn Q3 2024 Earnings of ($0.05) Per Share (NASDAQ:ENTX) - Defense World

Aug 15, 2024
pulisher
Aug 15, 2024

Entera Bio Ltd. to Post Q3 2024 Earnings of ($0.05) Per Share, HC Wainwright Forecasts (NASDAQ:ENTX) - MarketBeat

Aug 15, 2024
pulisher
Aug 13, 2024

Entera Bio Ltd. (NASDAQ:ENTX) Short Interest Down 51.0% in July - MarketBeat

Aug 13, 2024
pulisher
Aug 12, 2024

Entera Bio (NASDAQ:ENTX) Releases Earnings Results - MarketBeat

Aug 12, 2024
pulisher
Aug 12, 2024

Entera Bio's (ENTX) Buy Rating Reaffirmed at HC Wainwright - MarketBeat

Aug 12, 2024
pulisher
Aug 12, 2024

HC Wainwright Reiterates Buy Rating for Entera Bio (NASDAQ:ENTX) - Defense World

Aug 12, 2024
pulisher
Aug 09, 2024

Entera Bio Reports Q2 2024 Financial Results and Provides Business Updates - GlobeNewswire

Aug 09, 2024
pulisher
Aug 09, 2024

Virtu Financial LLC Invests $37,000 in Entera Bio Ltd. (NASDAQ:ENTX) - Defense World

Aug 09, 2024
pulisher
Aug 07, 2024

Entera Bio Ltd expected to post a loss of 6 cents a shareEarnings Preview - XM

Aug 07, 2024
pulisher
Aug 06, 2024

The 10 Best Biotech Stocks Under $5 To Buy For December 2024! - The Stock Dork

Aug 06, 2024
pulisher
Aug 02, 2024

Entera Bio shareholders approve executive compensation, board appointments - Investing.com

Aug 02, 2024
pulisher
Aug 01, 2024

Entera’s EB613, the First Once Daily PTH(1-34) Tablet Treatment Dedicated to Post-Menopausal Women with High Risk Osteoporosis Abstract Selected for Presentation at the ASBMR 2024 Annual MeetingKey SABRE Update Also Expected - StockTitan

Aug 01, 2024
pulisher
Aug 01, 2024

Entera Bio (NASDAQ:ENTX) Trading Up 1.9% - MarketBeat

Aug 01, 2024

Entera Bio Ltd (ENTX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Entera Bio Ltd (ENTX) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Taitel Haya
Director
Jan 10 '24
Buy
0.77
7,615
5,864
25,615
LIEBERMAN GERALD M
Director
Dec 22 '23
Buy
0.71
23,952
17,006
226,961
Toledano Miranda Jayne
Chief Executive Officer
Dec 22 '23
Buy
0.71
23,952
17,006
110,752
$17.87
price down icon 2.88%
$68.84
price up icon 2.65%
$39.39
price down icon 0.43%
$359.58
price down icon 0.16%
$176.50
price up icon 1.02%
$113.08
price up icon 1.56%
大文字化:     |  ボリューム (24 時間):